{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:40:04Z","timestamp":1750534804512,"version":"3.41.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 23-year-old woman presenting with gross hematuria was found to have a left renal mass suspicious for renal cell carcinoma on abdominal contrast-enhanced CT. An <jats:sup>18<\/jats:sup>F-PSMA-1007 PET\/CT scan was performed for evaluating the renal mass. <jats:sup>18<\/jats:sup>F-PSMA-1007 PET\/CT showed focal activity of the renal mass, which was a transcription factor E3-rearranged renal cell carcinoma proved after nephrectomy. Surprisingly, diffuse heterogeneous intense activity of the bilateral breasts and moderate activity of the right accessory breast was observed. There was no morphological abnormality of the bilateral breasts and right accessory breast on CT images, indicating physiological PSMA uptake.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005260","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T16:01:21Z","timestamp":1716393681000},"page":"693-694","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Diffuse Intense 18F-PSMA-1007 Uptake of the Breasts in a Woman With TFE3-Rearranged Renal Cell Carcinoma"],"prefix":"10.1097","volume":"49","author":[{"given":"Qian","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisheng","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjing","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.euf.2018.08.004","article-title":"The role of radiolabeled prostate-specific membrane antigen positron emission tomography\/computed tomography for the evaluation of renal cancer","volume":"6","year":"2020","journal-title":"Eur Urol Focus"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3390\/jcm11071829","article-title":"PSMA PET\/CT in renal cell carcinoma: an overview of current literature","volume":"11","year":"2022","journal-title":"J Clin Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/RLU.0000000000003002","article-title":"18F-PSMA 1007 in suspected renal cell carcinoma","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/RLU.0000000000004162","article-title":"Incremental value of 18F-PSMA-1007 PET\/CT in detection of metastatic renal cell carcinoma to the brain","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/RLU.0000000000003354","article-title":"18F-PSMA-1007 PET\/CT for initial staging of renal cell carcinoma in an end-stage renal disease patient","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/RLU.0000000000003664","article-title":"Utility of 18F-prostate-specific membrane antigen 1007 in imaging of tumor thrombus of renal cell carcinoma","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00259-020-05165-3","article-title":"18F-PSMA-1007 PET\/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAI.0000000000001142","article-title":"Vascular expression of prostate-specific membrane antigen (PSMA) in MiTF family translocation renal cell carcinoma and related neoplasms","volume":"31","year":"2023","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10585-018-9878-x","article-title":"Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases","volume":"34","year":"2017","journal-title":"Clin Exp Metastasis"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1097\/RLU.0000000000005084","article-title":"Reversibility of bicalutamide PSMA PET-positive gynecomastia with androgen deprivation therapy","volume":"49","year":"2024","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1097\/RLU.0000000000001742","article-title":"False positive uptake in bilateral gynecomastia on 68Ga-PSMA PET\/CT scan","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/RLU.0000000000002086","article-title":"Re: false positive uptake in bilateral gynecomastia on 68Ga-PSMA PET\/CT scan","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/MNM.0000000000000566","article-title":"Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET\/CT imaging","volume":"37","year":"2016","journal-title":"Nucl Med Commun"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"e190037","DOI":"10.1148\/rycan.2020190037","article-title":"Management of incidental breast lesions detected at nuclear medicine examinations","volume":"2","year":"2020","journal-title":"Radiol Imaging Cancer"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.semnuclmed.2019.02.006","article-title":"Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: an update on important pitfalls","volume":"49","year":"2019","journal-title":"Semin Nucl Med"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1097\/RLU.0000000000004549","article-title":"Incidental diagnosis of metastatic breast cancer in a man with 99mTc-PSMA SPECT\/CT","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/RLU.0000000000004978","article-title":"68Ga-PSMA-11 uptake in a large fibroadenoma in a male axillary accessory breast","volume":"49","year":"2024","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:01:48Z","timestamp":1750532508000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005260","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2024,5,21]]}}}